GREEN

And he’s still never explained this

Yeah all the most famous sad cat edits are mine. My stuff has been in music videos, painted on buildings in New York, and much more.

🚨 ATENÇÃO l Adultos estão chupando chupeta como forma de aliviar o estresse

I'm learning how the new X system works. I got my start here making famous sad cat memes 10 years ago. Then I let my sense of humor take over and made some huge internet-swaying movements just by being funny and sharing original hot takes. I just learned my account isn’t growing because I no longer make sad cat memes and the new direction is hurting my brand based on what my bio said. This is so confusing and frustrating. My bio has been adjusted and I’ll continue having fun with all my frens. Here’s to growing and learning. I just wish we had some direction on what we’re doing right and wrong. Here’s to learning from mistakes and growing.

“So my cousin was ran over” anyways here are my BIG FAT TITS

What kind of appliance is this?

Sorry bub

Once you see the Passenger, there’s no stopping what’s coming. 𖨆 Get tickets now for Passenger - only in theatres Friday

But I’d have to lose them

Scientists in Japan have developed a groundbreaking treatment that could double the average lifespan of cats, extending it from around 15 years to nearly 30 years. The key lies in a protein called AIM (Apoptosis Inhibitor of Macrophage), discovered by Dr. Toru Miyazaki. While cats naturally produce AIM, they lack the ability to activate it effectively. This deficiency leads to the gradual buildup of waste in the kidneys, the leading cause of death in domestic cats. Dr. Miyazaki’s team created an injectable form of activated AIM that directly restores the kidneys’ natural cleaning function. In clinical trials, cats with advanced kidney disease showed dramatic improvement after treatment. The therapy works both as a preventive measure for healthy cats and as a treatment for those already ill. If approved, the treatment could revolutionize feline healthcare. Commercial rollout is expected to begin in Japan as early as 2025, with wider availability projected for 2027. The research has also sparked interest for its potential applications in human medicine, as the AIM protein plays a similar waste-clearing role across species.